Answers are grounded in this paper and cite their sources.
This month's installment of “The AJT Report” discusses the long-awaited passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act and its expected impact. We also report on a controversial new policy affecting organ procurement organizations.
No takes yet. Share an insight, caveat, or question.
Lara C. Pullen (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: